Drawing for ZEQMELIT

USPTO serial 79362118

ZEQMELIT

Reviewed by CopyMark Law Group

Reg. 7452016Status 700Registered
Filing date
Status date
Registration date
Jul 23, 2024
Examiner
SMITH, CYNTHIA RINALDI
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZEQMELIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical, medical and veterinary preparations and nutritional supplements; Pharmaceuticals, medical and veterinary preparations containing dexamethasone for treatment of allergic reactions, croup, nausea, post-operative vomiting as a side effect of other medical treatment, asthma, inflammation, immunodeficiency, muscle cramp and virus related illnesses; Pharmaceuticals, medical and veterinary preparations containing cortisone for treatment of allergic reactions, croup, nausea, post-operative vomiting as a side effect of other medical treatment, asthma, inflammation, immunodeficiency, muscle cramp and virus related illnesses; Pharmaceutical and veterinary preparations for treating allergic reactions, croup, nausea, post-operative vomiting as a side effect of other medical treatment, asthma, inflammation, immunodeficiency and muscle crampACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 26, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2025EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Feb 26, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 10, 2025FIMPFINAL DISPOSITION PROCESSED
Oct 23, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 12, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 12, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 8, 2024GPNXNOTIFICATION PROCESSED BY IB
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 22, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 22, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2023RFNTREFUSAL PROCESSED BY IB
Oct 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 18, 2023RFRRREFUSAL PROCESSED BY MPU
Oct 4, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 3, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2023DOCKASSIGNED TO EXAMINER
Feb 14, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Feb 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance